|
|
|
British Journal of Pharmacology (2001) 132, 500, 506; doi: 10.1038/sj.bjp.0703826
Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B
Moussa B H Youdim1,2, Aviva Gross1 and John P M Finberg1
|
|
|
Rasagiline Phase III Clinical Program
|
|